Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Henry

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Diabetes, Obesity & Metabolism|March 3, 2015
Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trialsR R Henry, J B Buse, H Wu, et al.
International Journal of Clinical Practice|August 7, 2008
Is adiposopathy (sick fat) an endocrine disease?H E Bays, J M González-Campoy, R R Henry, et al.
Cancer Research|May 15, 1998
Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RDE S Knudsen, C Pazzagli, T L Born, et al.
Diabetes, Obesity & Metabolism|November 6, 2009
Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetesS Mudaliar, A R Chang, V R Aroda, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2001
Early alteration in glomerular reserve in humans at genetic risk of essential hypertension: mechanisms and consequencesD T O'Connor, E A Tyrell, M T Kailasam, et al.
Diabetes Care|May 1, 1994
Nutrition principles for the management of diabetes and related complicationsM J Franz, E S Horton, J P Bantle, et al.
Diabetes, Obesity & Metabolism|August 6, 2013
Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone--a factorial studyR R Henry, B Staels, V A Fonseca, et al.
Diabetes, Obesity & Metabolism|May 11, 2011
Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetesR R Henry, S R Smith, S L Schwartz, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 1998
Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gammaK S Park, T P Ciaraldi, K Lindgren, et al.
JAMA|May 11, 1994
Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitusA Garg, J P Bantle, R R Henry, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Diabetes, Obesity & Metabolism|March 3, 2015
Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trialsR R Henry, J B Buse, H Wu, et al.
International Journal of Clinical Practice|August 7, 2008
Is adiposopathy (sick fat) an endocrine disease?H E Bays, J M González-Campoy, R R Henry, et al.
Cancer Research|May 15, 1998
Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RDE S Knudsen, C Pazzagli, T L Born, et al.
Diabetes, Obesity & Metabolism|November 6, 2009
Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetesS Mudaliar, A R Chang, V R Aroda, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2001
Early alteration in glomerular reserve in humans at genetic risk of essential hypertension: mechanisms and consequencesD T O'Connor, E A Tyrell, M T Kailasam, et al.
Diabetes Care|May 1, 1994
Nutrition principles for the management of diabetes and related complicationsM J Franz, E S Horton, J P Bantle, et al.
Diabetes, Obesity & Metabolism|August 6, 2013
Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone--a factorial studyR R Henry, B Staels, V A Fonseca, et al.
Diabetes, Obesity & Metabolism|May 11, 2011
Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetesR R Henry, S R Smith, S L Schwartz, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 1998
Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gammaK S Park, T P Ciaraldi, K Lindgren, et al.
JAMA|May 11, 1994
Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitusA Garg, J P Bantle, R R Henry, et al.
Pageof 13